ホーム › 前立腺がん › アリゾナ州 › Scottsdale
Scottsdale、AZにおける前立腺がんの臨床試験
Scottsdaleとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
被験者募集中第3相
- Mayo Clinic in Arizona, Scottsdale
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
被験者募集中第3相
- Mayo Clinic, Scottsdale
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
被験者募集中第3相
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Scottsdale
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
被験者募集中第2/3相
- Honor Health Research Institute, Scottsdale
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
被験者募集中
- Mayo Clinic, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
被験者募集中第1相
- HonorHealth, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
被験者募集中第1/2相
- Honor Health Research Institute, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Honor Health, Scottsdale
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
被験者募集中第2相
- HonorHealth Research Institute, Scottsdale
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
被験者募集中早期第1相
- Mayo Clinic in Arizona, Scottsdale
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
被験者募集中第1/2相
- Honor Health, Scottsdale
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
被験者募集中第4相
- Mayo Clinic Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Scottsdale
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Scottsdaleにおける他の研究
- 乳がん18件の研究
- がん（全種類）18件の研究
- 転移性癌17件の研究
- 大腸癌16件の研究
- 非小細胞肺癌15件の研究
- 膵臓がん13件の研究
- 悪性黒色腫10件の研究
- 潰瘍性大腸炎8件の研究
- 肺がん8件の研究
- 肝臓がん（肝細胞がん）7件の研究
- アルツハイマー病7件の研究
- トリプルネガティブ乳がん7件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。